Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

University of Chicago Medicine Comprehensive Cancer Center Joins OncLiveÂ® in Strategic Alliance Partnership Program

February 2nd 2015

OncLive® welcomes the University of Chicago Medicine Comprehensive Cancer Center as a partner in raising the standard of cancer care through OncLive's Strategic Alliance Partnership program.

FDA Expands Approval of Ibrutinib to Waldenström’s macroglobulinemia

January 29th 2015

The FDA has expanded the approval of ibrutinib for the treatment of patients with Waldenström’s macroglobulinemia, according to a press release.

Sidney Kimmel Comprehensive Cancer Center of Johns Hopkins Medicine Joins OncLive in Strategic Alliance Partnership Program

January 28th 2015

OncLive® and the Sidney Kimmel Comprehensive Cancer Center of Johns Hopkins Medicine have become collaborators to raise awareness of leading innovations in cancer care through OncLive's Strategic Alliance Partnership program, OncLive announced.

Dr. DeVita Discusses the 10th Edition of Cancer: Principles and Practice of Oncology

January 28th 2015

Giant of Cancer Care, Vincent T. DeVita, Jr, MD, from the Yale School of Medicine, talks about the 10th Edition of Cancer: Principles and Practice of Oncology, an internationally acclaimed book geared toward practicing oncologists.

Dawn of US Biosimilar Era Arrives

January 26th 2015

2015 has certainly got off to an exciting start in oncology!

Cancer Care Payments Tied to Alternative Payment Methods, Says Medicare

January 26th 2015

Alternative payment methods in cancer care are front and center in a Medicare initiative to have 85% of all fee-for-service payments tied to quality or value by 2016, and 90% by 2018.

17 Cancer Drugs on Breakthrough Therapy List

January 23rd 2015

The FDA is evaluating proposals for new indications for at least 17 oncology medicines, according to Friends of Cancer Research.

CancerLinQ To Be Rolled Out to 15 Community Practices, Large Cancer Centers

January 21st 2015

The first iteration of the American Society of Clinical Oncology's (ASCO's) endeavor to capture and harness big data, CancerLinQ, is scheduled for release in late 2015.

114th Congress Sets Sights on SGR Patch

January 14th 2015

With a March 31 deadline looming for the 114th Congress to either patch or repeal the sustainable growth rate (SGR) formula, the Health Subcommittee of the US House of Representatives' Energy and Commerce Committee will hold a hearing to discuss the future of the fundamentally flawed formula used to set Medicare physician payments.

Dr. Cookson on Ideal Bladder Cancer Biomarkers

January 13th 2015

No one biomarker is effective for all types of bladder cancer, says Michael Cookson, MD, a professor and chairman of the Department of Urology at the University of Oklahoma College of Medicine.

OncLive Welcomes Stephenson Cancer Center to Strategic Alliance Partnership Program

January 12th 2015

OncLive® and Stephenson Cancer Center, the only comprehensive academic cancer center in Oklahoma, have become partners in raising the standard of cancer care through OncLive's Strategic Alliance Partnership program, OncLive announced.

13 Drugs to Watch in 2015

January 12th 2015

The FDA's calendar for making decisions on new oncology drugs and indications is taking shape for 2015, and the clock is ticking on at least 13 applications for novel agents and new therapeutic settings for existing drugs.

ODAC Unanimously Supports Approval of First Biosimilar

January 7th 2015

In a 14-0 vote, the FDA's ODAC unanimously recommended approval of EP2006, a biosimilar version of filgrastim. If the FDA follows the recommendation, the drug would become the first biosimilar approved in the United States.

Chemotherapy Parity Laws Ignore Cost, Quality Question

January 2nd 2015

With the FDA approval of several oral chemotherapy agents, the cost of medications to treat cancer is increasing rapidly. To control costs, legislators, patient advocates, and physicians have pushed for oral chemotherapy parity laws.

"Perverse Incentives" Add Costs to Dying Patients

December 29th 2014

Sweeping changes to the way America delivers care at the end of life would better serve patients and their families, while achieving the goals sought in the Affordable Care Act (ACA) of better health, cost savings, and especially patient satisfaction

There's No Place Like a Medical Home: Premier Medical Group Focuses on Full-scale Patient-Centered Care

December 28th 2014

It's not uncommon for a business to use a superlative in its name, but Premier Medical Group in Poughkeepsie, NY, truly lives up to its moniker.

Will Oncology Care in the Future Look Vastly Different From Today?

December 26th 2014

It is always fun to try to predict the future. Invariably you will be wrong.

Collaboration in Groups Improves Care, Averts Pay Cuts

December 24th 2014

Urologists who are members of LUGPA are doing the right thing by being part of large group practices.

FDA Approves Nivolumab for Advanced Melanoma

December 22nd 2014

The FDA has approved the PD-1 inhibitor nivolumab for patients with unresectable or metastatic melanoma following treatment with ipilimumab or a BRAF inhibitor.

Dreams of Opening a Solo Practice Dwindling Says Survey of Future Docs

December 22nd 2014

Only 10% of current medical students aspire to open up shop as a solo practitioner-a 50% drop since 2008. Last year, 17% of students surveyed said that solo practice was a consideration. On the other hand, those students who anticipate seeking employment with a large group practice or hospital has risen to 73%, as compared with 70% last year.